Expression of CD44 in kidney after acute ischemic injury in rats

被引:91
作者
Lewington, AJP
Padanilam, BJ
Martin, DR
Hammerman, MR
机构
[1] Washington Univ, Sch Med, Dept Med, Div Renal,George M OBrien & Urol Dis Ctr, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
关键词
acute renal failure; hyaluronic acid; matrix; osteopontin; arginine-glycine-aspartate peptides;
D O I
10.1152/ajpregu.2000.278.1.R247
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
De novo CD44 and ligand expression at wound margins accompanies cellular proliferation and migration that effect repair of injured mucosal and vascular endothelial tissues. To determine whether CD44 could play a role in recovery from acute ischemic renal injury, we characterized its renal. expression and those of two of its ligands, hyaluronic acid and osteopontin. Although no expression is detectable in nonischemic kidneys, several mRNAs for CD44 are present within 1 day after injury. CD44 mRNA is expressed in proximal tubules undergoing repair. CD44 peptide is present in basal and lateral cell membranes. Hyaluronic acid is normally expressed in the interstitium of the renal papilla only. By 1 day postischemia, hyaluronic acid can be detected, in addition, in the interstitium surrounding regenerating tubules. Osteopontin, not normally expressed in the renal proximal tubule, is expressed in regenerating tubules by 3 days after induction of acute ischemic injury. Immunoreactive osteopontin peptide continues to be localized in those tubules still undergoing repair for as long as 7 days after the injury. Our data are consistent with a role for CD44-ligand interactions in the regenerating proximal tubule participating in the process of recovery after ischemic injury.
引用
收藏
页码:R247 / R254
页数:8
相关论文
共 26 条
[1]   Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury [J].
Basile, DP ;
Rovak, JM ;
Martin, DR ;
Hammerman, MR .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 270 (03) :F500-F509
[2]  
Borland G, 1998, IMMUNOLOGY, V93, P139
[3]   Insulin-like growth factor I preserves renal function postoperatively [J].
Franklin, SC ;
Moulton, M ;
Sicard, GA ;
Hammerman, MR ;
Miller, SB .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 272 (02) :F257-F259
[4]   CHARACTERIZATION OF HYALURONIC-ACID ON TISSUE-SECTIONS WITH HYALURONECTIN [J].
GIRARD, N ;
DELPECH, A ;
DELPECH, B .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1986, 34 (04) :539-541
[5]  
Jain A, 1996, NEUROL INDIA, V44, P97
[6]   CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis [J].
Jun, Z ;
Hill, PA ;
Lan, HY ;
Foti, R ;
Mu, W ;
Atkins, RC ;
NikolicPaterson, DJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (01) :69-77
[7]   UP-REGULATION OF OSTEOPONTIN EXPRESSION BY ISCHEMIA IN RAT-KIDNEY [J].
KLEINMAN, JG ;
WORCESTER, EM ;
BESHENSKY, AM ;
SHERIDAN, AM ;
BONVENTRE, JV ;
BROWN, D .
OSTEOPONTIN: ROLE IN CELL SIGNALLING AND ADHESION, 1995, 760 :321-323
[8]  
Liaw L, 1998, J CLIN INVEST, V101, P1468
[9]   EXPRESSION AND MODULATION OF CD44 VARIANT ISOFORMS IN HUMANS [J].
MACKAY, CR ;
TERPE, HJ ;
STAUDER, R ;
MARSTON, WL ;
STARK, H ;
GUNTHERT, U .
JOURNAL OF CELL BIOLOGY, 1994, 124 (1-2) :71-82
[10]   RAT MODELS FOR CLINICAL USE OF INSULIN-LIKE GROWTH-FACTOR-I IN ACUTE-RENAL-FAILURE [J].
MILLER, SB ;
MARTIN, DR ;
KISSANE, J ;
HAMMERMAN, MR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :F949-F956